FDA gives Ab­b­Vie ac­cel­er­at­ed ap­proval for an­ti­body-drug con­ju­gate in lung can­cer

The FDA ap­proved a new an­ti­body-drug con­ju­gate from Ab­b­Vie on Wednes­day to treat pa­tients with cer­tain kinds of lung can­cer.

Reg­u­la­tors grant­ed ac­cel­er­at­ed ap­proval to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER